Let’s be clear. The primary reason to be vaccinated against shingles is that two shots provide 90 percent protection against ...
The Arizona Wildcats head into Big 12 Conference play carrying significant momentum after a perfect non-conference record and ...
Praxis Precision Medicines remains a Hold as valuation now reflects high expectations for ulixacaltamide and its epilepsy ...
Ultragenyx rebounded by 15.52 percent on Tuesday to close at $22.78 apiece as investors resorted to bargain-hunting following ...
The emergence of next-generation KRAS G12C inhibitors has led Verastem Oncology to change course. | The emergence of ...
A San Diego startup may have created what the scientific community has talked about for decades – a kind of universal flu ...
Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (Orbit) or bisphosphonates ...
A rare Baggy Green cap personally given by Sir Donald Bradman to a fellow Test cricketer will be auctioned, with bidding set ...
Ultragenyx Pharmaceutical (RARE) remains a Sell after its Phase 3 OI program failed to meet primary fracture reduction ...
Zacks.com on MSN
Kyverna Therapeutics Stock Up 41% in a Month: Here's Why
KYTX's shares surge after positive phase II data showed its CAR T miv-cel delivered major mobility gains in stiff person syndrome.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results